Cargando…
Concurrent and reactivation of hepatitis B virus infection in diffuse large B-cell lymphoma: risk factors and survival outcome
OBJECTIVE: To determine the clinical features and survival difference of HBV related and Non-HBV related diffuse large B-cell lymphoma (DLBCL) and to evaluate the occurrence of HBV reactivation in DLBCL patients and related risk factors for HBV reactivation after R-CHOP therapy. METHODS: A total of...
Autores principales: | Guo, Ya-fei, Pan, Jing-xin, Zhuang, Wei-huang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292058/ https://www.ncbi.nlm.nih.gov/pubmed/30559832 http://dx.doi.org/10.1186/s13027-018-0215-4 |
Ejemplares similares
-
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
por: Chen, Kai-Lin, et al.
Publicado: (2015) -
Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma
por: Wang, Yanchun, et al.
Publicado: (2018) -
A Hepatitis B Virus Reactivation Case Potentially Triggered by the Onset of Diffuse Large B Cell Lymphoma
por: Sato, Kentaro, et al.
Publicado: (2022) -
Concurrent Pilomatrix Carcinoma and Diffuse Large B-Cell Lymphoma
por: Parra, Luis, et al.
Publicado: (2016) -
MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection
por: Liu, Zhihe, et al.
Publicado: (2017)